RU92016463A - APPLICATION OF DERIVATIVES OF TISSTINES FOR THE MANUFACTURE OF MEDICINES WITH IMMUNOMODING EFFECT, PHARMACEUTICAL COMPOSITIONS ON THEIR BASIS - Google Patents

APPLICATION OF DERIVATIVES OF TISSTINES FOR THE MANUFACTURE OF MEDICINES WITH IMMUNOMODING EFFECT, PHARMACEUTICAL COMPOSITIONS ON THEIR BASIS

Info

Publication number
RU92016463A
RU92016463A RU92016463/14A RU92016463A RU92016463A RU 92016463 A RU92016463 A RU 92016463A RU 92016463/14 A RU92016463/14 A RU 92016463/14A RU 92016463 A RU92016463 A RU 92016463A RU 92016463 A RU92016463 A RU 92016463A
Authority
RU
Russia
Prior art keywords
derivatives
tisstines
immunomoding
medicines
manufacture
Prior art date
Application number
RU92016463/14A
Other languages
Russian (ru)
Other versions
RU2119793C1 (en
Inventor
Александер Андерссон Карл-Магнус
Хокан Аксель Бергстранд Стен
Рудольф Халлберг Андерс
Олоф Сернстранд Бенгт
Андерс Сигвард Тунек Пер
Original Assignee
Актиеболагет Астра
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE9002067A external-priority patent/SE9002067D0/en
Priority claimed from SE9002275A external-priority patent/SE9002275D0/en
Application filed by Актиеболагет Астра filed Critical Актиеболагет Астра
Publication of RU92016463A publication Critical patent/RU92016463A/en
Application granted granted Critical
Publication of RU2119793C1 publication Critical patent/RU2119793C1/en

Links

Claims (1)

Настоящее изобретение относится к способу лечения заболеваний, связанных с нарушениями в иммунной системе организма, путем использования некоторых производных цистина и фармацевтических препаратов, содержащих эти производные.The present invention relates to a method of treating diseases associated with disorders in the immune system of the body, through the use of certain cystine derivatives and pharmaceutical preparations containing these derivatives.
RU92016463A 1990-06-08 1991-06-03 Substances exhibiting immunomodulating effect, pharmaceutical composition based on thereof, method of immunomodulation RU2119793C1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
SE9002067-8 1990-06-08
SE9002067A SE9002067D0 (en) 1990-06-08 1990-06-08 THE PHARMACOLOGICAL USE OF CERTAIN CYSTINE DERIVATIVES
SE9002275-7 1990-06-28
SE9002275A SE9002275D0 (en) 1990-06-28 1990-06-28 NOVEL 3,3'-DITHIOBIS (PROPIONIC ACIDS)

Publications (2)

Publication Number Publication Date
RU92016463A true RU92016463A (en) 1995-09-10
RU2119793C1 RU2119793C1 (en) 1998-10-10

Family

ID=26660796

Family Applications (1)

Application Number Title Priority Date Filing Date
RU92016463A RU2119793C1 (en) 1990-06-08 1991-06-03 Substances exhibiting immunomodulating effect, pharmaceutical composition based on thereof, method of immunomodulation

Country Status (20)

Country Link
US (2) US5441976A (en)
EP (1) EP0532595B1 (en)
JP (1) JP3204320B2 (en)
KR (1) KR100236253B1 (en)
AT (1) ATE144705T1 (en)
AU (1) AU652946B2 (en)
CA (1) CA2083274C (en)
DE (1) DE69122961T2 (en)
DK (1) DK0532595T3 (en)
HK (1) HK62597A (en)
HU (1) HU215920B (en)
IE (1) IE80754B1 (en)
IL (1) IL98310A (en)
LV (2) LV10186B (en)
NO (1) NO924723D0 (en)
NZ (1) NZ247658A (en)
PT (1) PT97905B (en)
RU (1) RU2119793C1 (en)
SG (1) SG49736A1 (en)
WO (1) WO1991018594A1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9018994D0 (en) * 1990-08-31 1990-10-17 Secr Defence Toxic agent protective compounds
US5889050A (en) * 1991-06-21 1999-03-30 Astra Aktiebolag 3,3'-dithiobis (propionic acids) and esters thereof
SE9103572D0 (en) * 1991-11-29 1991-11-29 Astra Ab ORGANIC SALTS OF N, N'-DIACETYL CYSTINE
JP2947044B2 (en) * 1993-01-27 1999-09-13 味の素株式会社 Adjuvant therapy for immunodeficiency syndrome treatment
DE4329857C2 (en) * 1993-09-03 1995-08-24 Deutsches Krebsforsch Connection to strengthen the immune system and immune reactions
SE9500897D0 (en) * 1995-03-14 1995-03-14 Astra Ab The pharmacological use of certain cysteine derivatives
SE9501067D0 (en) * 1995-03-24 1995-03-24 Astra Ab New peptides
SE9602262D0 (en) * 1996-06-06 1996-06-06 Astra Ab New use of cystine derivatives
US20030203006A1 (en) * 1997-10-29 2003-10-30 Ajinomoto Co. Inc. Immunomodulator
US6197749B1 (en) 1997-10-29 2001-03-06 Ajinomoto Co., Inc. Method of suppressing immune responses by reducing intracellular content of glutathione in macrophages and monocytes
EP1120407B1 (en) 1998-10-09 2013-02-20 Ajinomoto Co., Inc. Cystine derivatives
EP1004302A3 (en) * 1998-10-29 2003-06-04 Ajinomoto Co., Inc. Immunomodulator
SE9900438D0 (en) * 1999-02-10 1999-02-10 Astra Ab The pharmacological use of certian cystine derivatives
JP3988014B2 (en) * 2000-02-02 2007-10-10 味の素株式会社 Antiviral agent
PT2283817T (en) 2000-11-30 2016-08-22 Vectura Ltd Method of making particles for use in a pharmaceutical composition
SE518784C2 (en) * 2000-12-27 2002-11-19 Nactilus Ab "N-Acetyl-L-Cysteine with Compositions for the Treatment of Neoplasms"
US8530509B2 (en) 2003-06-20 2013-09-10 Siga Technologies, Inc. Compounds, compositions and methods for treatment and prevention of orthopoxvirus infections and associated diseases
DE102004043055B4 (en) 2004-09-06 2009-04-02 Siemens Ag Guide device for guiding a movable machine element of a machine
WO2008066603A2 (en) * 2006-10-03 2008-06-05 Galleon Pharmaceuticals, Inc. S-nitrosothiol compounds and related derivatives
MX348481B (en) * 2007-04-23 2017-06-15 Siga Tech Inc Chemicals, compositions, and methods for treatment and prevention of orthopoxvirus infections and associated diseases.
US7829709B1 (en) 2007-08-10 2010-11-09 Marquette University Cysteine prodrugs to treat schizophrenia and drug addiction
JP5796881B2 (en) * 2008-02-07 2015-10-21 マーケット ユニバーシティー Cysteine and cystine prodrugs to treat schizophrenia and reduce drug craving
JP6458809B2 (en) 2014-04-25 2019-01-30 味の素株式会社 Immunostimulator

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR8205M (en) * 1968-12-20 1970-09-14
US3878305A (en) * 1972-05-25 1975-04-15 Procter & Gamble Fortification of foodstuffs with n-acyl derivatives of sulphur-containing l-amino acids
US3952115A (en) * 1975-04-02 1976-04-20 The Procter & Gamble Company Fortification of foodstuffs with N-acyl derivatives of sulfur-containing L-amino acid esters
FR2503151A1 (en) * 1981-04-02 1982-10-08 Morelle Jean Compsns. contg. N-butyryl alpha-aminoacid(s) - for cosmetic, hygienic, therapeutic or agricultural use
GB2097256B (en) * 1981-04-02 1985-05-30 Morelle Jean V Compositions containing n-butyryl alphaaminoacids
US4827016A (en) * 1985-09-16 1989-05-02 Morgan Lee R Method and compounds for reducing dermal inflammations
US4724239A (en) * 1985-09-16 1988-02-09 Morgan Lee R Method of treating chemical ulcers with N,N'-diacetylcystine, N-acetyl homocysteine and N-acetyl cysteine
US4708965A (en) * 1985-09-16 1987-11-24 Morgan Lee R Method of treating herpes virus infections with N,N'-diacetylcystine and derivatives
IT1249650B (en) * 1991-05-29 1995-03-09 Poli Ind Chimica Spa N- (5-TIOXO-L-PROLIL) -L-CISTEIN AND ITS DERIVATIVES, THEIR PREPARATION AND THERAPEUTIC USE

Similar Documents

Publication Publication Date Title
RU92016463A (en) APPLICATION OF DERIVATIVES OF TISSTINES FOR THE MANUFACTURE OF MEDICINES WITH IMMUNOMODING EFFECT, PHARMACEUTICAL COMPOSITIONS ON THEIR BASIS
BG101118A (en) Therapeutical compounds
ATE210127T1 (en) 6-SUBSTITUTED MYCOPHENOLIC ACID DERIVATIVES WITH IMMUNE SUPPRESSIVE EFFECTS
ES2137948T3 (en) ADVANCED SYSTEM OF ADMINISTRATION OF MEDICINES AND METHOD OF TREATMENT OF PSYCHIATRIC, NEUROLOGICAL AND OTHER DISORDERS WITH CARBAMACEPINE.
IL91276A0 (en) Pharmaceutical compositions containing alpha-amino boronic acid derivatives,for the prophylaxis and treatment of virus diseases
DE68929388D1 (en) Anticoagulant compound isolated from urine
IT8322855A0 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF PERIPHERAL ARTERIAL DISEASE.
IT8619055A0 (en) PHARMACEUTICAL COMPOSITIONS INCLUDING PEPTIDES OF THE CHOLECYSTOKININ-CERULIN GROUP FOR THE THERAPEUTIC TREATMENT OF SHOCK STATES AND RESPIRATORY AND CARDIOCIRCULAR INSUFFICIENCY.
IT8009551A0 (en) E-5-(2-HALOGENOVINIL-)-2'DEOXYCYTIDINES, THEIR METHOD OF PREPARATION AND THEIR USE FOR THE TREATMENT OF VIRUS DISEASES
NO165071C (en) ANALOGUE PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 7- (3-AMINO-1-PYRROLIDINYL) -8-CHLORO-1-CYCLOPROPYL-6-FLUORO-1,4, -DIHYDRO-4-OXO-3-CHINOLINE-CARBOXYL.
ATA99191A (en) MEDICINAL PRODUCT PROTEIN C
ES2089286T3 (en) NEW 2-AMINO-5-CIANO-1,4-DIHIDROPIRIDINAS, PROCEDURE FOR ITS PREPARATION AND USE IN MEDICINES.
ATE5256T1 (en) PHENYLPIPERAZIN DERIVATIVES OF 1,3,4OXADIAZOLYLPENOLS, THEIR PREPARATION AND THERAPEUTIC AGENTS CONTAINING THEM.
ATE27157T1 (en) CYCLOALKYL DERIVATIVES OF BENZISOSELENAZOLONES, PROCESS FOR THEIR PRODUCTION AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM.
DE3380923D1 (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DISORDERS CONDITIONED BY HUMAN DRUGS.
OA07270A (en) N- (vinblastinoyl-23) amino acid derivatives, their preparation and therapeutic application.
ATE28566T1 (en) CELL-TOXIC MEDICINAL PRODUCT CONTAINING AT LEAST AN IMMUNOTOXIN AND AN AMINE.
ES2060440T3 (en) DERIVATIVES OF 1,4-DIHIDROPIRIDIN-DICARBOXILICOS ACIDS ARIL-QUINOLIL SUBSTITUTED, PROCEDURE FOR ITS MANUFACTURE AND ITS USE IN MEDICINES.
DE68905076D1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF SKIN Wounds.
ES2160927T3 (en) PHARMACEUTICAL COMPOSITIONS THAT INCLUDE INTERFERED NATURAL HUMAN ALPHA.
DE3064854D1 (en) Quail-egg lyophilisate for the treatment of immuno-allergic diseases
SE8802323D0 (en) 8ALFA-ACYLAMINOERGOLINE, ITS PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING IT
RU93052408A (en) ACYLAMINO-ALKYLIDENE-HYDROXY-BIS-PHOSPHONE ACIDS, METHOD FOR THEIR PRODUCTION, PHARMACEUTICAL COMPOSITION
EP0038153A3 (en) Modified allergens
IT1246050B (en) USE OF HEPTASTIGMIN IN CEREBRAL STROKE THERAPY.